Vincent Willey
Overview
Explore the profile of Vincent Willey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Desai K, Teng C, Sturm D, Stockbower G, Patadia H, et al.
Clinicoecon Outcomes Res
. 2025 Feb;
17:69-77.
PMID: 39931253
Purpose: Many patients with atopic dermatitis (AD), a highly pruritic, relapsing, inflammatory skin disease, experience inadequate disease control. Ruxolitinib cream was approved in the US in September 2021 for the...
2.
Ketkar A, Willey V, Glasser L, Dobie C, Wenziger C, Teng C, et al.
Adv Ther
. 2024 Jan;
41(3):1075-1102.
PMID: 38216825
Introduction/methods: EPOCH-US is an ongoing, retrospective, observational cohort study among individuals identified in the Healthcare Integrated Research Database (HIRD) with ≥ 12 months of continuous health plan enrollment. Data were...
3.
Ketkar A, Willey V, Pollack M, Glasser L, Dobie C, Wenziger C, et al.
Curr Med Res Opin
. 2023 Jul;
39(8):1103-1118.
PMID: 37431293
Objective: To estimate the prevalence of patients with an immunocompromising condition at risk for COVID-19, estimate COVID-19 prevalence rate (PR) and incidence rate (IR) by immunocompromising condition, and describe COVID-19-related...
4.
Quint J, Montonen J, Singh D, Wachtel H, Attick S, Palli S, et al.
Expert Rev Respir Med
. 2022 Mar;
16(4):485-493.
PMID: 35325585
Introduction: Discordance between real-world prescribing patterns and global treatment guidelines for the treatment of chronic obstructive pulmonary disease (COPD) with inhaled single or dual long-acting bronchodilator maintenance therapy is increasingly...
5.
Chen X, Wang Z, Bromfield S, DeVries A, Pryor D, Willey V
Pragmat Obs Res
. 2021 May;
12:9-13.
PMID: 33935528
No abstract available.
6.
Parlett L, Ma Q, Shi Q, Crawford G, Herrera Scott L, Willey V, et al.
Diabetol Metab Syndr
. 2021 Apr;
13(1):47.
PMID: 33883009
This claims-based retrospective cohort study examined the prevalence and incremental impact of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus in the United States. Although diagnoses of non-alcoholic steatohepatitis...
7.
Visaria J, Iyer N, Raval A, Kong S, Hobbs T, Bouchard J, et al.
Clin Ther
. 2019 Jun;
41(8):1522-1536.e1.
PMID: 31196656
Purpose: The relationship between type 2 diabetes mellitus (T2DM) and increased microvascular and macrovascular disease and mortality is well established; however, data for the broad US T2DM population, especially by...
8.
Willey V, Franchino-Elder J, Fu A, Wang C, Sander S, Tan H, et al.
BMJ Open
. 2018 Jul;
8(6):e020676.
PMID: 29961012
Objectives: With the approval of new non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation (NVAF), it is anticipated that their introduction may change NVAF treatment patterns;...
9.
Wu B, Bell K, Stanford A, Kern D, Tunceli O, Vupputuri S, et al.
BMJ Open Diabetes Res Care
. 2016 Apr;
4(1):e000154.
PMID: 27110365
Objective: To describe the estimated prevalence and temporal trends of chronic kidney disease (CKD) treatment patterns, and the association between CKD and potential factors for type 2 diabetes mellitus (T2DM)...
10.
Donato B, Burns L, Willey V, Cohenuram M, Oliveria S, Yood M
Clin Ther
. 2010 Apr;
32(3):546-54.
PMID: 20399992
Objective: The aim of this work was to analyze chemotherapy treatment patterns in patients with advanced breast cancer who had been previously exposed to an anthracycline, a taxane, and capecitabine....